Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards
share
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Therapeutic antibodi

FA Immuno

QuestionAnswer
CD52 Alemtuzumab
CLL Alemtuzumab
colorectal Ca, RCC Bavacizumab
Stage IV colorectal Ca, head and neck Ca Cetuximab
B cell non-Hodgkin lymphoma, CLL, RA, ITP Rituximab
Breast Ca Trastuzumab
VEGF Ranibizumab, bevacizumab
EGFR Cetuximab
CD20 Rituximab
Her2/neu Trastuzumab
Soluble TNF alpha Adalimumab, infliximab
IBD, RA, Ankylosing spondylitis, psoriasis Adalimumab, infliximab
decoy TNF alpha receptor Etanercept
Complement protein C5 Eculizumab
PNH Eculizumab
alpha 4 integrin Natalizumab
MS, Crohn disease Natalizumab
Platelet glycoprotein IIb/IIIa Abciximab
antiplatelet agent for prevention of ischemic complications in patients undergoing percutaneous coronary intervention Abciximab
RANKL Denosumab
osteoporosis Denosumab
inhibits osteoclast maturation (mimics osteoprotegerin) Denosumab
Antidote for digoxin toxicity Digoxin immune Fab
IgE Omalizumab
Allergic asthma, prevents IgE binding to FcERI Omalizumab
RSV F Protein Palivizumab
RSV prophylaxis for high risk infants Palivizumab
neovascular age related macular degeneration Ranibizumab, bevacizumab
Created by: Syrica